This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lyons, C. N.
Right arrow Articles by White, T. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyons, C. N.
Right arrow Articles by White, T. C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, September 2000, p. 2296-2303, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Transcriptional Analyses of Antifungal Drug Resistance in Candida albicans

Chris N. Lyons and Theodore C. White*

Department of Pathobiology, School of Public Health and Community Medicine, University of Washington and the Seattle Biomedical Research Institute

Received 16 November 1999/Returned for modification 22 March 2000/Accepted 7 June 2000

Oral infections with the pathogenic yeast Candida albicans are one of the most frequent and earliest opportunistic infections in human immunodeficiency virus-infected patients. The widespread use of azole antifungal drugs has led to the development of drug-resistant isolates. Several molecular mechanisms that contribute to drug resistance have been identified, including increased mRNA levels for two types of efflux pump genes: the ATP binding cassette transporter CDRs (CDR1 and CDR2) and the major facilitator MDR1. Using Northern blot analyses, the expression patterns of these genes have been determined during logarithmic and stationary phases of cell growth and during growth in different carbon sources in a set of matched susceptible and fluconazole-resistant isolates that have been characterized previously. MDR1, CDR1, and CDR2 are expressed early during logarithmic growth, CDR4 is expressed late during logarithmic growth, and CDR1 is preferentially expressed in stationary-phase cells. There is a small decrease in expression of these genes when the cells are grown in carbon sources other than glucose. While increased mRNA levels of efflux pump genes are commonly associated with azole resistance, the causes of increased mRNA levels have not yet been resolved. Southern blot analysis demonstrates that the increased mRNA levels in these isolates are not the result of gene amplification. Nuclear run-on assays show that MDR1 and CDR mRNAs are transcriptionally overexpressed in the resistant isolate, suggesting that the antifungal drug resistance in this series is associated with the promoter and trans-acting factors of the CDR1, CDR2, and MDR1 genes.

* Corresponding author. Mailing address: Seattle Biomedical Research Institute, 4 Nickerson St., Suite 200, Seattle, WA 98109-1651. Phone: (206) 284-8846, ext. 344. Fax: (206) 284-0313. E-mail: tedwhite{at}u.washington.edu.

Antimicrobial Agents and Chemotherapy, September 2000, p. 2296-2303, Vol. 44, No. 9
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Manoharlal, R., Gaur, N. A., Panwar, S. L., Morschhauser, J., Prasad, R. (2008). Transcriptional Activation and Increased mRNA Stability Contribute to Overexpression of CDR1 in Azole-Resistant Candida albicans. Antimicrob. Agents Chemother. 52: 1481-1492 [Abstract] [Full Text]  
  • Oliver, B. G., Song, J. L., Choiniere, J. H., White, T. C. (2007). cis-Acting Elements within the Candida albicans ERG11 Promoter Mediate the Azole Response through Transcription Factor Upc2p. Eukaryot Cell 6: 2231-2239 [Abstract] [Full Text]  
  • Riggle, P. J., Kumamoto, C. A. (2006). Transcriptional Regulation of MDR1, Encoding a Drug Efflux Determinant, in Fluconazole-Resistant Candida albicans Strains through an Mcm1p Binding Site. Eukaryot Cell 5: 1957-1968 [Abstract] [Full Text]  
  • Lepak, A., Nett, J., Lincoln, L., Marchillo, K., Andes, D. (2006). Time Course of Microbiologic Outcome and Gene Expression in Candida albicans during and following In Vitro and In Vivo Exposure to Fluconazole.. Antimicrob. Agents Chemother. 50: 1311-1319 [Abstract] [Full Text]  
  • Harry, J. B., Oliver, B. G., Song, J. L., Silver, P. M., Little, J. T., Choiniere, J., White, T. C. (2005). Drug-Induced Regulation of the MDR1 Promoter in Candida albicans. Antimicrob. Agents Chemother. 49: 2785-2792 [Abstract] [Full Text]  
  • Chau, A. S., Mendrick, C. A., Sabatelli, F. J., Loebenberg, D., McNicholas, P. M. (2004). Application of Real-Time Quantitative PCR to Molecular Analysis of Candida albicans Strains Exhibiting Reduced Susceptibility to Azoles. Antimicrob. Agents Chemother. 48: 2124-2131 [Abstract] [Full Text]  
  • Song, J. L., Harry, J. B., Eastman, R. T., Oliver, B. G., White, T. C. (2004). The Candida albicans Lanosterol 14-{alpha}-Demethylase (ERG11) Gene Promoter Is Maximally Induced after Prolonged Growth with Antifungal Drugs. Antimicrob. Agents Chemother. 48: 1136-1144 [Abstract] [Full Text]  
  • Woyke, T., Berens, M. E., Hoelzinger, D. B., Pettit, G. R., Winkelmann, G., Pettit, R. K. (2004). Differential Gene Expression in Auristatin PHE-Treated Cryptococcus neoformans. Antimicrob. Agents Chemother. 48: 561-567 [Abstract] [Full Text]  
  • Lee, M.-K., Williams, L. E., Warnock, D. W., Arthington-Skaggs, B. A. (2004). Drug resistance genes and trailing growth in Candida albicans isolates. J Antimicrob Chemother 53: 217-224 [Abstract] [Full Text]  
  • Mukherjee, P. K., Chandra, J., Kuhn, D. M., Ghannoum, M. A. (2003). Mechanism of Fluconazole Resistance in Candida albicans Biofilms: Phase-Specific Role of Efflux Pumps and Membrane Sterols. Infect. Immun. 71: 4333-4340 [Abstract] [Full Text]  
  • Rogers, P. D., Barker, K. S. (2003). Genome-Wide Expression Profile Analysis Reveals Coordinately Regulated Genes Associated with Stepwise Acquisition of Azole Resistance in Candida albicans Clinical Isolates. Antimicrob. Agents Chemother. 47: 1220-1227 [Abstract] [Full Text]  
  • Lupetti, A., Paulusma-Annema, A., Welling, M. M., Dogterom-Ballering, H., Brouwer, C. P. J. M., Senesi, S., van Dissel, J. T., Nibbering, P. H. (2003). Synergistic Activity of the N-Terminal Peptide of Human Lactoferrin and Fluconazole against Candida Species. Antimicrob. Agents Chemother. 47: 262-267 [Abstract] [Full Text]  
  • Rogers, P. D., Barker, K. S. (2002). Evaluation of Differential Gene Expression in Fluconazole-Susceptible and -Resistant Isolates of Candida albicans by cDNA Microarray Analysis. Antimicrob. Agents Chemother. 46: 3412-3417 [Abstract] [Full Text]  
  • White, T. C., Holleman, S., Dy, F., Mirels, L. F., Stevens, D. A. (2002). Resistance Mechanisms in Clinical Isolates of Candida albicans. Antimicrob. Agents Chemother. 46: 1704-1713 [Abstract] [Full Text]  
  • Hof, H. (2001). Critical Annotations to the Use of Azole Antifungals for Plant Protection. Antimicrob. Agents Chemother. 45: 2987-2990 [Full Text]  
  • Marr, K. A., Lyons, C. N., Ha, K., Rustad, T. R., White, T. C. (2001). Inducible Azole Resistance Associated with a Heterogeneous Phenotype in Candida albicans. Antimicrob. Agents Chemother. 45: 52-59 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»